123 Results

People

  1. Motzer
    Motzer
  2. Saltz
    Saltz
  3. Dickler
    Dickler
  4. Jaimes
    Jaimes
  5. Glezerman
    Glezerman
  6. Miller
    Miller
  7. Aghajanian
    Aghajanian
  8. Flombaum
    Flombaum
  9. Hudis
    Hudis
  10. Lichtman
    Lichtman

Groups

  1. Department of Medicine (82)
  2. Solid Tumor Oncology Division (63)
  3. Genitourinary Oncology Service (23)
  4. Division of Subspecialty Medicine (17)
  5. Renal (16)
  6. Gastrointestinal Oncology Service (15)
  7. Gynecologic Medicine Service (13)
  8. Center for Hematologic Malignancies (12)
  9. Hematologic Malignancies, Division of (12)
  10. Survivorship Research (12)
  1. "proteinuria"
Formats
  1. Journal Article (116)
  2. Review (3)
  3. Book Section (2)
  4. Research Letter (2)
Groups
  1. Department of Medicine (82)
  2. Solid Tumor Oncology Division (63)
  3. Genitourinary Oncology Service (23)
  4. Division of Subspecialty Medicine (17)
  5. Renal (16)
  6. Gastrointestinal Oncology Service (15)

More Groups

People
  1. Robert Motzer (19)
  2. Leonard Saltz (8)
  3. Ilya Glezerman (7)
  4. Edgar Jaimes (6)
  5. Maura Dickler (6)
  6. Vincent Miller (5)

More People

Years
  1. 2025 (3)
  2. 2024 (9)
  3. 2023 (5)
  4. 2022 (2)
  5. 2021 (3)
  6. 2020 (8)

More Years

Publications
  1. Journal of Clinical Oncology (11)
  2. Clinical Cancer Research (5)
  3. Lancet Oncology (5)
  4. The Oncologist (4)
  5. Annals of Oncology (3)
  6. Cancer Science (3)

More Publications

Publishers
  1. Elsevier Inc. (25)
  2. Oxford University Press (12)
  3. American Society of Clinical Oncology (11)
  4. Elsevier Science, Inc. (8)
  5. Nature Publishing Group (8)
  6. Wiley Blackwell (7)

More Publishers

Results (123)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Nivolumab plus cabozantinib versus sunitinib for advanced renal-cell carcinoma
    Journal Article

    Choueiri, T. K.; Powles, T.; Burotto, M.; Escudier, B.; Bourlon, M. T.; Zurawski, B.; Oyervides Juárez, V. M.; Hsieh, J. J.; Basso, U.; Shah, A. Y.; more...
    New England Journal of Medicine (2021)

    Fulltext@MSK | Save
  • Combination antiangiogenic tyrosine kinase inhibition and anti-PD1 immunotherapy in metastatic renal cell carcinoma: A retrospective analysis of safety, tolerance, and clinical outcomes
    Journal Article

    Laccetti, A. L.; Garmezy, B.; Xiao, L.; Economides, M.; Venkatesan, A.; Gao, J.; Jonasch, E.; Corn, P.; Zurita-Saavedra, A.; Brown, L. C.; more...
    Cancer Medicine (2021)

    Fulltext@MSK | Save
  • Hematologic malignancies
    Book Section

    Gupta, M.; Latcha, S.
    In Finkel, K. W.; Perazella, M. A.; Cohen, E. P. (Eds.) Onco-Nephrology (2020)

    Fulltext@MSK | Save
  • BCR-ABL tyrosine kinase inhibitor (TKI)-induced nephropathy: An under-recognized phenomenon
    Journal Article

    Stanchina, M.; McKinnell, Z.; Park, J. H.; Stein, E. M.; Cai, S. F.; Taylor, J.
    Leukemia Research Reports (2020)

    Fulltext@MSK | Save
  • Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: A multicentre, open-label, phase 2 study
    Journal Article

    Abou-Alfa, G. K.; Sahai, V.; Hollebecque, A.; Vaccaro, G.; Melisi, D.; Al-Rajabi, R.; Paulson, A. S.; Borad, M. J.; Gallinson, D.; Murphy, A. G.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Phase I study of trifluridine/tipiracil plus irinotecan and bevacizumab in advanced gastrointestinal tumors
    Journal Article

    Varghese, A. M.; Cardin, D. B.; Hersch, J.; Benson, A. B.; Hochster, H. S.; Makris, L.; Hamada, K.; Berlin, J. D.; Saltz, L. B.
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Renal toxicity of systemic therapy for renal cell carcinoma
    Review

    Jaimes, E. A.
    Seminars in Nephrology (2020)

    Fulltext@MSK | Save
  • Avelumab plus axitinib vs sunitinib for advanced renal cell carcinoma: Japanese subgroup analysis from JAVELIN Renal 101
    Journal Article

    Uemura, M.; Tomita, Y.; Miyake, H.; Hatakeyama, S.; Kanayama, H. O.; Numakura, K.; Takagi, T.; Kato, T.; Eto, M.; Obara, W.; more...
    Cancer Science (2020)

    Fulltext@MSK | Save
  • Clinical features and outcomes of immune checkpoint inhibitor-associated AKI: A multicenter study
    Journal Article

    Cortazar, F. B.; Kibbelaar, Z. A.; Glezerman, I. G.; Abudayyeh, A.; Mamlouk, O.; Motwani, S. S.; Murakami, N.; Herrmann, S. M.; Manohar, S.; Shirali, A. C.; more...
    Journal of the American Society of Nephrology (2020)

    Fulltext@MSK | Save
  • A phase I study of intravenous or intraperitoneal platinum based chemotherapy in combination with veliparib and bevacizumab in newly diagnosed ovarian, primary peritoneal and fallopian tube cancer
    Journal Article

    Moore, K. N.; Miller, A.; Bell-McGuinn, K. M.; Schilder, R. J.; Walker, J. L.; O'Cearbhaill, R. E.; Guntupalli, S. R.; Armstrong, D. K.; Hagemann, A. R.; Gray, H. J.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save